Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.

Co-located with our

COMMERCIAL EXCELLENCE SUMMIT

eyeforpharma Japan 2018 Real World Evidence 11th Annual|May 16-17, 2018

Key topics to be covered:

We are currently putting together the agenda for the 2018 event, contact Ting (tgao@eyeforpharma.com) for more details

08:30 - 09:00
See what’s possible: Explore the rich opportunities and challenges for your company over the next few years
  • Be aware of the market changes brought by the imminent, next-generation medical infrastructure laws. Understand the necessary preparation and precautions.
  • Use RWD to become a real ‘corporate citizen’ by measuring and improving your contribution to the health of local communities and society at large
  • RWE is now an essential capability for your company: see how your mastery of data sourcing and analysis will improve your medical affairs, PV, market access and marketing functions
08:30 - 09:00
Create access to the real world: a spotlight on some of the newest RWD opportunities and their application
  • A review of available data sources and how you can best use them
  • The expected benefits and guidelines of using large, government-led large databases
  • Registry data: witness the latest progress and how you can take advantage
  • Considerations when using PHR (Personal Health Record) data: a ‘different kind of RWD.’ Explore the implications and applications
  • Can the ‘my number’ system help you overcome the data-combination problem? Understand how it will help you from 2020 onwards
08:30 - 09:00
Make it happen: maximise the potential of your RWE studies
  • Set up your research questions first –ensure you are creating the best study design before querying data
  • Tips and techniques for ensuring reliability of your data and robust conclusions
  • Validation studies: necessary steps to avoid failure
  • From data to evidence: use different indexes to demonstrate the health outcomes clearly from your RWD studies
  • Witness some of the latest technologies and analysis techniques that will boost your visibility
08:30 - 09:00
Successful implementation: deliver the best RWE study for the right application
  • Clinical studies: how does real world evidence improve our understanding of disease
  • Pharmacovigilance (PV): how RWE can be used to ensure drug safety and correct usage
  • Market access: learn how RWE can support HTA as it develops in Japan, and ensure it aligns with your pricing strategy
  • Expand your horizons by understanding the RWE trends in US/Europe – and learn the lessons you can apply to Japan
08:30 - 09:00
Into the future: understand the newest applications of RWE and how it can improve the trajectory of your company in a value-based health economy
  • See how other new technologies can combine with RWD for improving effectiveness
  • Evolve your organisation: envision the most effective organizational structure for the future RWE era
  • How should the whole healthcare industry change in to align with the expanding utilisation of RWE?
Anza Asahara

Anza Asahara

Regional Project Director
eyeforpharma

Phone: +44 (0) 207 422 4312

Email: anza@eyeforpharma.com

Ting Gao

Ting Gao

Head of Partnerships, Asia
eyeforpharma

Phone: +44 (0) 207 422 4308

Email: tgao@eyeforpharma.com

Pre-order the detailed event brochure

Complete speaker line-up • Program for all tracks & sessions • Audience breakdown